NCPA's qAM

qAM

FDA seeks nominations for compounding advisory committee

by NCPA | Feb 11, 2019

The FDA has issued a call for nominations for nonvoting industry representatives to serve on 17 of the Center for Drug Evaluation and Research's public advisory committees, including the Pharmacy Compounding Advisory Committee. The agency is also calling for industry groups to participate in the selection process. FDA advisory committees include four types of members: scientific/medical experts, consumers, patients, and industry representatives. Nominations for the nonvoting industry representative positions must be submitted within 30 days. Selected members will serve a four-year term beginning Nov. 1.